The ACR Bulletin Podcast

In this Imaging 3.0 case study, one radiology group leveraged artificial intelligence to significantly improve adherence to evidence-based guidelines. Read the case study for further information.  

Farouk Dako, MD, MPH, discusses how radiology can use predictive analytics to positively impact health equity.

Richard E. Heller III, MD, MBA, discusses the challenges and opportunities associated with ending surprise billing in radiology.

Nathan Coleman, MD, discusses the challenge of providing price transparency in radiology.

Samir Patel, MD, FACR, discusses the Radiology Value-Added Matrix, a data visualization tool that demonstrates radiology's value to the c-suite.

Farouk Dako, MD, MPH, examines the importance of advancing radiology in underserved areas, along with the virtues of radiologic public health informatics.

Howard Fleishon, MD, MMM, FACR, and Gregory Nicola, MD, Discuss E/M CPT Coding Changes

Etta Pisano, MD, discusses a range of ACR-related projects that directly address the COVID-19 pandemic, including the ACR COVID-19 Imaging Research Registry, or CIRR.

Howard Fleishon, MD, MMM, FACR, discusses reimagining several of the ACR’s focus areas during the COVID era and beyond.

Cody Quirk, MD, discusses the " Hounsfield Unit Podcast ," a podcast he hosts that focuses on what matters most to Young and Early Career Professionals, along with Residents and Fellows.

(Running time 14 minutes) Geraldine McGinty, MD, MBA, FACR, discusses the formation of the Radiology Health Equity Coalition and its mission to ensure that the best care is provided to every patient, regardless of background or income level.

(Running time 22 minutes) In this episode, Lincoln Berland, MD, FACR, discusses the upcoming publication of results from the ACR Task Force on Certification in Radiology. Dr. Berland is Professor Emeritus, Department of Radiology at the University of Alabama at Birmingham and is a past member of ACR’s Board of Chancellors, where he served as Chair of the Commission on Body Imaging. 

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Patricia Rivera about the impact of the COVID-19 pandemic on lung cancer screening.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Patricia Rivera about the importance of biomarker testing for patients with advanced NSCLC.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Patricia Rivera about the proposed USPSTF lung cancer screening guidelines.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Patricia Rivera, MD about the impact COVID-19 has had on lung caner screening programs across the country.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Patricia Rivera about disparities in eligibility criteria for, access to, and implementation of lung cancer screening.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Ron Simmons about the risks related to lung cancer.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Ron Simmons about the patient perspective of being diagnosed with lung cancer.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Ron Simmons about the demographics of patients who get screened for lung cancer.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Ron Simmons about his cancer journey.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Linda Dowling about lung cancer screening amidst COVID-19 pandemic.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Linda Dowling about what the patients should know about lung cancer screening.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Linda Dowling about the myths surround the lung cancer screening process.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Linda Dowling about smoking cessation and stigma in the lung cancer screening setting.